Anna Bruynzeel, MD, PhD

Anna M.E. Bruynzeel, MD PhD, is a radiation oncologist at Amsterdam UMC, The Netherlands. She specializes in MR-guided radiotherapy, stereotactic body radiotherapy (SABR), and the treatment of pancreatic, renal, and brain tumors. Dr. Bruynzeel has played a leading role in the clinical implementation of daily adaptive MRgRT and is principal or co-investigator in multiple national and international prospective trials. Her research focuses on personalized radiotherapy strategies and integrating novel image guidance techniques into clinical care. She is an invited speaker at numerous international conferences and actively contributes to national guideline development and multicenter research collaborations.

Disclosures:

• Employment: academic hospital:Amsterdam UMC:Employee
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none